- Contract Awards
An Abbott Laboratories (NYSE: ABT) business segment has secured an approximately $255 million indefinite-delivery/indefinite-quantity contract from the Defense Logistics Agency for 50 million units of a rapid point-of-care antigen test for COVID-19. Abbott Rapid DX North America will produce and supply its BinaxNOW COVID-19 Ag Card in support of the...








